[go: up one dir, main page]

PE20051158A1 - PHARMACEUTICAL COMPOSITIONS INCLUDING A COMBINATION OF EPINASTIN AND ONE OR MORE ADDITIONAL MINERALS OR ONE OR MORE ROUGH DRUGS - Google Patents

PHARMACEUTICAL COMPOSITIONS INCLUDING A COMBINATION OF EPINASTIN AND ONE OR MORE ADDITIONAL MINERALS OR ONE OR MORE ROUGH DRUGS

Info

Publication number
PE20051158A1
PE20051158A1 PE2005000324A PE2005000324A PE20051158A1 PE 20051158 A1 PE20051158 A1 PE 20051158A1 PE 2005000324 A PE2005000324 A PE 2005000324A PE 2005000324 A PE2005000324 A PE 2005000324A PE 20051158 A1 PE20051158 A1 PE 20051158A1
Authority
PE
Peru
Prior art keywords
epinastin
rough
drugs
combination
pharmaceutical compositions
Prior art date
Application number
PE2005000324A
Other languages
Spanish (es)
Inventor
Minoru Okada
Tetsuo Hayashi
Norimitsu Umehara
Shinichiro Katsuyama
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of PE20051158A1 publication Critical patent/PE20051158A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A61K31/55131,4-Benzodiazepines, e.g. diazepam or clozapine
    • A61K31/55171,4-Benzodiazepines, e.g. diazepam or clozapine condensed with five-membered rings having nitrogen as a ring hetero atom, e.g. imidazobenzodiazepines, triazolam
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06Fungi, e.g. yeasts
    • A61K36/07Basidiomycota, e.g. Cryptococcus
    • A61K36/076Poria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/23Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/23Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/233Bupleurum
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/23Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/234Cnidium (snowparsley)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/25Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/28Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A61K36/282Artemisia, e.g. wormwood or sagebrush
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/34Campanulaceae (Bellflower family)
    • A61K36/346Platycodon
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/48Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/484Glycyrrhiza (licorice)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/53Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/538Schizonepeta
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/57Magnoliaceae (Magnolia family)
    • A61K36/575Magnolia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/63Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
    • A61K36/634Forsythia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/70Polygonaceae (Buckwheat family), e.g. spineflower or dock
    • A61K36/708Rheum (rhubarb)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/73Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A61K36/736Prunus, e.g. plum, cherry, peach, apricot or almond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/74Rubiaceae (Madder family)
    • A61K36/744Gardenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/899Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
    • A61K36/8994Coix (Job's tears)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/90Smilacaceae (Catbrier family), e.g. greenbrier or sarsaparilla
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/906Zingiberaceae (Ginger family)
    • A61K36/9068Zingiber, e.g. garden ginger
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/04Antipruritics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/06Antipsoriatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Cosmetics (AREA)

Abstract

REFERIDA A UNA COMPOSICION FARMACEUTICA QUE COMPRENDE (A) EPINASTINA O SUS SALES PRESENTE(S) EN UN INTERVALO DE 1 A 50 mg; (B1) UNO O MAS MINERALES COMO CALCIO, CINC, FOSFORO, ENTRE OTROS, PRESENTE(S) EN UN INTERVALO DE 3 mg A 4000 mg; O (B2) UNO O MAS FARMACOS BRUTOS COMO AJENJO OLOROSA, FRUTO DE GARDENIA, RUIBARBO, HIEDRA, FLOR DE MAGNOLIA, ENTRE OTROS, PRESENTE(S) EN UNA INTERVALO DE 5 mg A 30000 mg. DICHOS COMPUESTOS SON EFICACES EN EL TRATAMIENTO DE ENFERMEDADES DE LA PIELREFERRING TO A PHARMACEUTICAL COMPOSITION INCLUDING (A) EPINASTIN OR ITS SALTS PRESENT (S) IN A RANGE OF 1 TO 50 mg; (B1) ONE OR MORE MINERALS SUCH AS CALCIUM, ZINC, PHOSPHORUS, AMONG OTHERS, PRESENT (S) IN A RANGE OF 3 mg TO 4000 mg; OR (B2) ONE OR MORE ROUGH DRUGS SUCH AS OLOROSA GARLIC, GARDENIA FRUIT, RUIBARB, IVY, MAGNOLIA FLOWER, AMONG OTHERS, PRESENT (S) IN AN INTERVAL OF 5 mg TO 30,000 mg. SUCH COMPOUNDS ARE EFFECTIVE IN THE TREATMENT OF SKIN DISEASES

PE2005000324A 2004-03-24 2005-03-22 PHARMACEUTICAL COMPOSITIONS INCLUDING A COMBINATION OF EPINASTIN AND ONE OR MORE ADDITIONAL MINERALS OR ONE OR MORE ROUGH DRUGS PE20051158A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP04007079 2004-03-24
EP04007080 2004-03-24

Publications (1)

Publication Number Publication Date
PE20051158A1 true PE20051158A1 (en) 2006-02-16

Family

ID=34962279

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2005000324A PE20051158A1 (en) 2004-03-24 2005-03-22 PHARMACEUTICAL COMPOSITIONS INCLUDING A COMBINATION OF EPINASTIN AND ONE OR MORE ADDITIONAL MINERALS OR ONE OR MORE ROUGH DRUGS

Country Status (5)

Country Link
EP (1) EP1735001A2 (en)
JP (1) JP2007530481A (en)
AR (1) AR049876A1 (en)
PE (1) PE20051158A1 (en)
WO (1) WO2005089803A2 (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2079460B1 (en) * 2006-10-20 2018-11-21 NUTRICOS Technologies Cosmetic oral use of glucosamine optionally in combination with at least one polyphenol compound
WO2008074896A1 (en) * 2006-12-21 2008-06-26 Prendergast Patrick T Compositions and methods for treatment of chronic neurological disorders
US7378082B1 (en) 2007-11-05 2008-05-27 Inspire Pharmaceuticals, Inc. Method for treating allergic rhinitis without adverse effects
JP5291324B2 (en) * 2007-11-01 2013-09-18 沢井製薬株式会社 Orally disintegrating tablets
JP6009791B2 (en) * 2012-03-28 2016-10-19 ホーユー株式会社 HDC activation inhibitor, HDC activation inhibitor composition, antipruritic agent and antipruritic composition
RU2521247C2 (en) * 2012-06-15 2014-06-27 Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Белгородская государственная сельскохозяйственная академия имени В.Я. Горина" METHOD OF TREATING BOVINE DIGITAL DERMATITIS (Dermatitis digitalis)
WO2014148136A1 (en) * 2013-03-19 2014-09-25 岐阜市 Compound having anti-allergic activity and use of same
CN103977243B (en) * 2014-06-06 2018-01-23 青岛市中心医院 A kind of medicine for treating uremia refractory pruritus and preparation method thereof
CN104547157A (en) * 2015-01-29 2015-04-29 陈文斌 External application preparation for repairing caesarean wound scar and preparation method thereof
JP7205074B2 (en) * 2017-05-02 2023-01-17 大正製薬株式会社 solid composition
CN108355090A (en) * 2018-04-11 2018-08-03 贵阳中医学院第二附属医院 A kind of drug and preparation method thereof for treating pruitus
CN112546204A (en) * 2019-09-10 2021-03-26 蔡娟 Oral care solution for treating hand-foot-and-mouth disease and dental ulcer and preparation method thereof
KR20230124624A (en) * 2020-12-24 2023-08-25 산텐 세이야꾸 가부시키가이샤 Pharmaceutical composition for topical administration containing epinastine or a salt thereof
CN116022757B (en) * 2022-12-26 2024-07-26 中南大学 Preparation method of battery-grade hydrated ferric phosphate

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0578243A (en) * 1990-12-11 1993-03-30 Shiseido Co Ltd Antipruritic agent and antipruritic composition
JPH07138173A (en) * 1993-11-15 1995-05-30 Kuga Takaaki Therapeutic agent for dermatopathy such as atopic dermatitis
JPH09208451A (en) * 1995-11-27 1997-08-12 Arusoa Oushiyou:Kk Anti-inflammatory agent for atopic constitution
JPH11100320A (en) * 1997-09-29 1999-04-13 Risuburan:Kk Preparation for external use for skin
JPH11158024A (en) * 1997-11-25 1999-06-15 Kobe Keiei Plan Kk Preparation of beautiful skin
CN1283115A (en) * 1997-12-23 2001-02-07 先灵公司 Composition for treating respiratory and skin diseases, comprising at least one leukotriene antagonist and at least one antihistamine
DE19831798A1 (en) * 1998-07-15 2000-01-27 Mandorlo Investment Gmbh Luxem Microcirculation improving skin and tissue care or treatment composition, containing salts, aminoacids and peroxide, used as cosmetic, medicament or nutrient supplement
US20020094345A1 (en) * 2000-10-06 2002-07-18 Sara Abelaira Pharmaceutical compositions containing epinastine and pseudoephedrine
JP4880816B2 (en) * 2000-12-15 2012-02-22 株式会社ヤクルト本社 Skin anti-aging agent
WO2002096406A1 (en) * 2001-05-25 2002-12-05 Ssp Co., Ltd. Medicinal compositions
DE10152973A1 (en) * 2001-10-26 2003-05-08 Boehringer Ingelheim Int New dry and watery Epinastin syrup formulation
JP2003146892A (en) * 2001-11-08 2003-05-21 Rohto Pharmaceut Co Ltd Cleaning agent
EP1531802A1 (en) * 2002-08-02 2005-05-25 Boehringer Ingelheim International GmbH Pharmaceutical formulations comprising combinations of epinastine, pseudoephedrine and methylephedrine
EP1468696A1 (en) * 2003-04-17 2004-10-20 Boehringer Ingelheim International GmbH Combinations of epinastine and antiphlogisitcs as new pharmaceutical compositions for the treatment of skin diseases

Also Published As

Publication number Publication date
AR049876A1 (en) 2006-09-13
EP1735001A2 (en) 2006-12-27
WO2005089803A3 (en) 2006-11-16
JP2007530481A (en) 2007-11-01
WO2005089803A2 (en) 2005-09-29

Similar Documents

Publication Publication Date Title
PE20051158A1 (en) PHARMACEUTICAL COMPOSITIONS INCLUDING A COMBINATION OF EPINASTIN AND ONE OR MORE ADDITIONAL MINERALS OR ONE OR MORE ROUGH DRUGS
GT200400126A (en) ANTITRANSPIRING ACTIVE COMPOUNDS OF ALUMINUM / ZIRCONY / GLYCINE, STABILIZED WITH BETAIN
GT200800184A (en) AMINOTETRAHYDROPIRANS AS INHIBITORS OF DIPEPTIDIL PEPTIDASA-IV FOR THE TREATMENT OR PREVENTION OF DIABETES.
CY1118519T1 (en) COMPOSITION OF TETRACYCLINS AND THEIR analogues
UY29406A1 (en) GAMMA CRYSTAL FORM OF IVABRADINE CHLORHYDRATE, ITS PREPARATION PROCEDURE AND PHARMACEUTICAL COMPOSITIONS CONTAINING IT.
ECSP066990A (en) FORMULATIONS WITH CONTROLLED RELEASE OF ACTIVE PRINCIPLE CONTAINING VARDENAFILO
UY30762A1 (en) SMOKE SALT OF (ALFA S, BETA R) -6-BROMO-ALFA- [2 (DIMETILAMINO) ETIL] -2-METOXI-ALFA-1-NAFTALENIL-BETA-PHENYL-3-QUINOLINAETHANOL
ECSP067120A (en) 3-AMINOCICLOPENTANOCARBOXAMIDS AS CHEMIOKIN RECEPTORS MODULATORS
GT200400218A (en) SUSTAINED RELEASE FORMULATIONS.
UY29407A1 (en) GAMMA-D CRYSTAL FORM OF IVABRADINE CHLORHYDRATE, ITS PREPARATION PROCEDURE AND PHARMACEUTICAL COMPOSITIONS CONTAINING IT.
SG178975A1 (en) Indenone derivative and pharmaceutical composition comprising same
CR10060A (en) 3-AMINOCICLOPENTANOCARBOXAMIDS AS CHEMIOKIN RECEPTORS MODULATORS
CL2011002766A1 (en) Carboxamide derived compounds, calpain inhibitors; pharmaceutical composition comprising them; and its use in the treatment of neurodegenerative diseases, alzahimer, pain, among others.
CL2008001820A1 (en) Aryl-isoxasol-imidazole derived compounds; preparation procedure; pharmaceutical composition containing them; and use in the preparation of useful drugs in the treatment of cognitive disorders and Alzheimer's-related diseases.
AR046319A1 (en) SALT OF TIOTROPY AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN IT.
EP1852114A4 (en) PREPARATION CONTAINING DIHOMO- (gamma) -LINOLENIC ACID (DGLA) AS ACTIVE INGREDIENT
BRPI0410044A (en) dosage form containing pantoprazole as active ingredient
UY33633A (en) ? SYNERGIC COMBINATION OF ABAMECTINE AND BIFENTRINE, ITS PREPARATION AND USE PROCESS, AND METHOD USING THE SAME "
GT200200249A (en) HERBICIDE COMPOSITION
DOP2006000280A (en) NEW SUBSTITUTED ACYCLIC FUROPIRIMIDINE DERIVATIVES AND THEIR USE
PE20090367A1 (en) CRYSTALLINE FORMS A AND B OF THE COMPOUND 3- (2R-TETRAHYDROFURYL-METHYL) -2-THIOXANTHINE
PE20051156A1 (en) ORAL MATRIX FORMULATIONS INCLUDING LICARBAZEPINE
DE602006009259D1 (en) PHARMACEUTICAL COMPOSITION COMPRISING ORGANIC ORGANIC FUEL
NI201000067A (en) GSM INTERMEDIARIES.
GT200900316A (en) PHARMACEUTICAL COMPOSITION UNDERSTANDING THE COMBINATION OF AN INHIBITING AGENT OF THE HMG-COA REDUCTASE ENZYME AND AN INHIBITING AGENT OF THE GASTROINTESTINAL ENZYME LIPASE

Legal Events

Date Code Title Description
FC Refusal